13F-HR filed by Darwin Global Management, Ltd.
Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 6 holding rows worth $1,055,769,131.
- Accession
- 0001892688-25-000094
- Filer
- CIK 1839209
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 6 entries on the cover page, a total value of $1,055,769,131 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,055,769,131 with VALUE read as dollars as filed, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 12,960,538 | $894,795,544 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 484,515 | $59,668,022 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 810,449 | $37,637,252 | dollars as filed | |
| GERON CORP | 374163103 | COM | 9,569,835 | $33,877,216 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,687,135 | $26,707,347 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 163,681 | $3,083,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-25-000094 | this filing | 2025-02-14 | acceptance time not in the bulk data set |